Aarti Drugs Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 7465.32 Crore) operating in Pharmaceuticals sector.
AgenciesPromoters held 60.2 per cent stake in the company as of Sept 30, 2020, while FIIs held 2.2 per cent, DIIs 1.9 per cent and public and others 35.8 per cent.
Axis Securities has buy call on Aarti Drugs with a target price of Rs 825. The current market price of Aarti Drugs Ltd. is Rs 799.75.
Aarti Drugs Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 7465.32 Crore) operating in Pharmaceuticals sector.
Financials For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 578.11 Crore, up 6.14 % from last quarter Sales of Rs 544.67 Crore and up 21.07 % from last year same quarter Sales of Rs 477.50 Crore Company reported net profit after tax of Rs 75.27 Crore in latest quarter.
Investment Rationale ARTD has planned to incur a Capex of INR 600 crore in next 3-4 years on upcoming seven projects. The Capex breakup maintenance comprises 20%, backward integration 40% and Greenfield expansion 40%. This Capex has potential to generate the sales of INR 1500 cr.
Promoter/FII Holdings Promoters held 60.2 per cent stake in the company as of Sept 30, 2020, while FIIs held 2.2 per cent, DIIs 1.9 per cent and public and others 35.8 per cent.
Agencies
Get Unlimited Access to The Economic Times
